These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28963823)

  • 21. Poor prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinomas that overexpress hypoxia inducible factor-1α.
    Swartz JE; Pothen AJ; van Kempen PM; Stegeman I; Formsma FK; Cann EM; Willems SM; Grolman W
    Head Neck; 2016 Sep; 38(9):1338-46. PubMed ID: 27027530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
    Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
    Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
    Keane FK; Chen YH; Neville BA; Tishler RB; Schoenfeld JD; Catalano PJ; Margalit DN
    Cancer; 2015 Aug; 121(15):2594-602. PubMed ID: 25873094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base.
    Amini A; Jasem J; Jones BL; Robin TP; McDermott JD; Bhatia S; Raben D; Jimeno A; Bowles DW; Karam SD
    Oral Oncol; 2016 May; 56():1-7. PubMed ID: 27086480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staging and treatment of oropharyngeal cancer in the human papillomavirus era.
    Ward MJ; Mellows T; Harris S; Webb A; Patel NN; Cox HJ; Piper K; Ottensmeier CH; Thomas GJ; King EV
    Head Neck; 2015 Jul; 37(7):1002-13. PubMed ID: 24753272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oropharyngeal carcinoma: A single institution study of 338 primaries with special reference to high-risk human papillomavirus-mediated carcinoma with aggressive behavior.
    Alexiev BA; Obeidin F; Johnson DN; Finkelman BS; Prince R; Somani SN; Cheng E; Samant S
    Pathol Res Pract; 2020 Dec; 216(12):153243. PubMed ID: 33113454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of time to simulation and treatment for patients with oropharyngeal cancer receiving definitive radiotherapy in the era of risk stratification using smoking and human papillomavirus status.
    Amsbaugh MJ; Yusuf M; Cash E; Silverman C; Potts K; Dunlap N
    Head Neck; 2018 Apr; 40(4):687-695. PubMed ID: 29356189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of the presence of HPV related oropharyngeal and oral tongue squamous cell carcinoma in Mozambique.
    Blumberg J; Monjane L; Prasad M; Carrilho C; Judson BL
    Cancer Epidemiol; 2015 Dec; 39(6):1000-5. PubMed ID: 26590333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma.
    van Kempen PM; Noorlag R; Braunius WW; Moelans CB; Rifi W; Savola S; Koole R; Grolman W; van Es RJ; Willems SM
    Cancer Med; 2015 Oct; 4(10):1525-35. PubMed ID: 26194878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior.
    Kraft S; Faquin WC; Krane JF
    Am J Surg Pathol; 2012 Mar; 36(3):321-30. PubMed ID: 22301491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in human papillomavirus-related oropharyngeal cancer in Israel.
    Amit M; Ilana K; Avraham SP; Binenbaum Y; Bachar G; Billan S; Zaarura S; Czerninski R; Bar-Tov M; Maly A; Akrish S; Gil Z
    Head Neck; 2016 Apr; 38 Suppl 1():E274-8. PubMed ID: 25545260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between T-stage and clinical nodal metastasis In HPV-positive oropharyngeal cancer.
    Sood AJ; McIlwain W; O'Connell B; Nguyen S; Houlton JJ; Day T
    Am J Otolaryngol; 2014; 35(4):463-8. PubMed ID: 24780201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA-Pk
    Weaver AN; Cooper TS; Wei S; Carroll WR; Rosenthal EL; Yang ES
    Head Neck; 2017 Feb; 39(2):206-214. PubMed ID: 27507640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus-associated oropharyngeal squamous cell carcinomas: primary tumor burden and survival in surgical patients.
    Ukpo OC; Pritchett CV; Lewis JE; Weaver AL; Smith DI; Moore EJ
    Ann Otol Rhinol Laryngol; 2009 May; 118(5):368-73. PubMed ID: 19548387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Squamous cell carcinoma metastatic to neck from an unknown primary: the potential impact of modern pathologic evaluation on perceived incidence of human papillomavirus-positive oropharyngeal carcinoma prior to 1970.
    Chenevert J; Seethala RR; Barnes EL; Chiosea SI
    Laryngoscope; 2012 Apr; 122(4):793-6. PubMed ID: 22252715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transoral robotic surgery for oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
    Mahmoud O; Sung K; Civantos FJ; Thomas GR; Samuels MA
    Head Neck; 2018 Apr; 40(4):710-721. PubMed ID: 29244238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative 18F-FDG PET/CT and high-risk HPV in patients with oropharyngeal squamous cell carcinoma.
    Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim MS
    Head Neck; 2014 Mar; 36(3):323-7. PubMed ID: 23729374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Redefining risk of contralateral cervical nodal disease in early stage oropharyngeal cancer in the human papillomavirus era.
    Smith AW; Gallitto M; Lehrer EJ; Wasserman I; Gupta V; Sharma S; Liu JT; Posner M; Misiukiewicz K; Westra WH; Genden EM; Haidar Y; Yao M; Teng MS; Miles BA; Bakst RL
    Head Neck; 2021 May; 43(5):1409-1414. PubMed ID: 33474814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.